Short Interest in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Declines By 20.8%

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) saw a large decline in short interest in the month of August. As of August 31st, there was short interest totalling 9,900 shares, a decline of 20.8% from the August 15th total of 12,500 shares. Based on an average trading volume of 17,700 shares, the days-to-cover ratio is currently 0.6 days.

Reviva Pharmaceuticals Stock Performance

RVPHW traded up $0.03 on Tuesday, reaching $0.14. The company had a trading volume of 1,039 shares, compared to its average volume of 17,372. The company has a fifty day moving average of $0.15 and a 200-day moving average of $0.34. Reviva Pharmaceuticals has a one year low of $0.07 and a one year high of $1.78.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.